China’s economic pledge stoked investor euphoria

Investors cheered Wednesday when China’s top economic policy czar promised a package of sweeping measures to support the nation’s economy and financial markets. To get more china economy latest news, you can visit shine news official website.

The pledge, announced by Vice Premier Liu He after convening a special meeting of the powerful State Counci... Read More

0 comments View Entry

Doing Business in China 2022

The Guide to Doing Business in China provides an introduction to selected aspects relating to investment and business operations in the People’s Republic of China (PRC or China) under current Chinese laws and policy during the COVID pandemic, including a summary of important areas of concern to all investors in China: mergers and acquisitions, data privacy issues, antitrust and competition issues, taxation, employment, intellectual property protection, tra... Read More

0 comments View Entry

China vows to stabilize markets and economy

China will keep the markets stable with favorable policies, China's Financial Stability and Development Committee said on Wednesday amid the recent market turmoil.To get more china economy latest news, you can visit shine news official website.

Policies that are favorable for the capital markets should be rolled out and unveiling of contractionary measures sh... Read More

0 comments View Entry

China’s GDP, dubious COVID statistics and East Timor’s election

The release of new economic data provided a temperature check of the world’s second-largest economy, while dubious COVID-19 death rates focused attention on Beijing’s reputation for secrecy and narrative control at all costs.To get more finance news China, you can visit shine news official website.

The first quarter performance bea... Read More

0 comments View Entry

Novartis Releases Positive Phase 1b/2 Clinical Data for JDQ443 for Treatment of NSCLC

Novartis released positive clinical data for JDQ443, an investigational selective, covalent, and orally bioavailable KRASG12C­ inhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2022, according to a statement from the company.To get more novartis updates, you can visit shine news official website.

0 comments View Entry